Filing Details
- Accession Number:
- 0001179110-19-007889
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-19 18:05:35
- Reporting Period:
- 2019-06-17
- Accepted Time:
- 2019-06-19 18:05:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1597264 | Blueprint Medicines Corp | BPMC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1769740 | Ariel Hurley | C/O Blueprint Medicines Corporation 45 Sidney Street Cambridge MA 02139 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-06-17 | 830 | $1.87 | 830 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2019-06-17 | 575 | $8.80 | 1,405 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-06-17 | 830 | $96.99 | 575 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-06-17 | 575 | $100.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2019-06-17 | 830 | $0.00 | 830 | $1.87 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2019-06-17 | 575 | $0.00 | 575 | $8.80 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
14,259 | 2024-10-08 | No | 4 | M | Direct | |
4,879 | 2025-02-10 | No | 4 | M | Direct |
Footnotes
- Effected pursuant to a trading plan adopted on December 17, 2018 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- This option was granted on October 8, 2014. This option vested with respect to 25% of the shares underlying the option on September 15, 2015 and vested as to an additional 1/48th of the shares underlying the option each month thereafter.
- This option was granted on February 10, 2015. This option vested with respect to 1/48th of the shares underlying the option on March 10, 2015 and vested as to an additional 1/48th of the shares underlying the option each month thereafter.